Markets News
Latest stock market news and real-time market analysis. Track S&P 500, Nasdaq, and Dow Jones movements, sector rotations, and breaking market events.
Lunai Bioworks Patent Deal Boosts Nasdaq Compliance Bid
Lunai Bioworks completed a $20 million patent acquisition via preferred stock, bolstering its Nasdaq listing compliance. Shares remain under $1.
XCF Global Targets June Restart for SAF Plant, Sets $120M Revenue Goal
XCF Global aims to restart its New Rise Reno SAF plant in June, targeting $110-$120M net revenue by 2027, with a pending merger with DevvStream and Southern Energy Renewables.
Cabaletta Bio Surges 32% on Early Cell Therapy Data and $150M Financing
Cabaletta Bio shares surged 32% on early cell therapy data and a $150M stock offering. Two of four patients showed clinical activity with rese-cel.
Filtronic Faces Key Test as Space and Defence Orders Await Tuesday Trading
Filtronic shares are under scrutiny as London markets reopen Tuesday, with investors eyeing the potential for recent space and defence contract wins to translate into larger, recurring revenue streams.
Mirum Surges on Volixibat Success in PSC Itch Trial, FDA Filing Targeted
Mirum Pharmaceuticals announced volixibat met its primary endpoint in a Phase 2b trial for PSC, reducing itch scores. Shares rose 9%. The company plans a pre-NDA FDA meeting this summer and a U.S. filing in H2 2026.
Sangamo Surges Ahead of Nasdaq Exit; OTCQB Switch Set for May 5
Sangamo Therapeutics shares surged roughly 33% on Monday as the company prepares to move from Nasdaq to the OTCQB Venture Market on May 5 following a delisting notice.
Above Food Ingredients Shares Surge 22% Amid Delayed Filing
Above Food Ingredients shares soared 22% to $0.65 in heavy trading Monday, as the company's fiscal 2025 annual report remains delayed due to ongoing audit issues.
Celcuity Surges 16% on Promising Breast Cancer Drug Data
Celcuity shares jumped 16% after its lead drug candidate, gedatolisib, met the primary endpoint in a Phase 3 breast cancer trial for PIK3CA-mutant tumors, setting the stage for a supplemental FDA filing.
MNDR Surges After $119M Hector Capital Pact for BIMA, M&M Helix Buys
Mobile-health Network Solutions shares surged about 60% following a non-binding $119 million framework with Hector Capital to fund acquisitions of BIMA and M&M Helix.
Skycorp Solar Surges on $20.2M Deal, Dilution Risks Loom
Skycorp Solar shares surged 88.8% after announcing a $20.2M stock-funded acquisition of Nanjing Cesun Power and a $3M private placement, raising dilution concerns.
Destiny Tech100 Soars on AI and SpaceX Hype
Destiny Tech100 shares jumped 13.4% Monday, driven by demand for its private tech holdings like SpaceX and AI firms. The fund trades at nearly double its NAV.